At the American Academy of Ophthalmology (AAO) 2026 Annual Meeting, Michael F. Chiang, MD, director of the National Eye ...
Projectiles such as grass, dirt, and rocks caused 77% of injuries, and eye protection, including eyeglasses, was documented ...
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable ...
TP53 mutations occurred in 3% of myeloproliferative neoplasms (MPNs) but 10% of myelofibrosis or blast-phase cohorts in a ...
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher ...
Key limitations included nonstandardized diagnostic criteria, proxy-derived activity/symptom measures, recall bias for ...
COA's Nicolas Ferreyros discusses real-world survival data for community oncology, health system consolidation, and barriers ...
The FDA has approved olanzapine extended-release injectable suspension (Weltruza; Teva Pharmaceuticals), a once-monthly ...
For patients with a blood cancer, the choice of a chimeric antigen receptor (CAR) T-cell therapy or a bispecific antibody is rarely a simple one, explains Kerry Rogers, MD, associate professor at The ...
The conference, held in New Orleans, Louisiana, by the American Academy of Ophthalmology, will offer 3 full days of content ...
A separate analysis of Aetna, Cigna, and UnitedHealthcare's 2025 TIC files, authored by Muhlestein and Yash Pathak and published in December 2025, found that physician and hospital outpatient data ...
The number of people living with heart failure (HF) worldwide more than doubled between 1990 and 2023, reaching an estimated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results